Novartis AG - Depositary Receipt (Common Stock)
US ˙ NYSE ˙ US66987V1098

SecurityNVS / Novartis AG - Depositary Receipt (Common Stock)
InstitutionSkopos Labs, Inc.
Latest Disclosed Ownership96,271 shares
Latest Disclosed Value $ 14,705,303
Skopos Labs, Inc. reports 48.23% increase in ownership of NVS / Novartis AG - Depositary Receipt (Common Stock)

On April 29, 2026 - Skopos Labs, Inc. filed a 13F-HR form disclosing ownership of 96,271 shares of Novartis AG - Depositary Receipt (Common Stock) (US:NVS) valued at $14,705,395 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 64,948 shares of Novartis AG - Depositary Receipt (Common Stock). This represents a change in shares of 48.23% during the quarter. The current value of the position is $14,359,782 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-29 2026-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 96,271 31,323 48.23 14,705 62.67 0.4594
2026-02-12 2025-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 64,948 43,420 201.69 9,041 249.98 0.4169
2025-11-14 2025-09-30 13F/A-2 NOVARTIS A G SPONSORED ADR 66987V109 21,528 -562 -2.54 2,584 -3.37 0.3489
2025-11-14 2025-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 42,255 20,165 5,419 0.3744
2025-08-14 2025-06-30 13F/A-1 NOVARTIS A G SPONSORED ADR 66987V109 22,090 15,064 214.40 2,673 241.38 0.3509
2025-08-12 2025-06-30 13F NOVARTIS A G SPONSORED ADR 66987V109 7,026 0 783 0.1691
2025-05-13 2025-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 7,026 6,463 1,147.96 783 1,350.00 0.1691
2025-01-15 2024-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 563 563 55 0.0163
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.